{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:14:39Z","timestamp":1789143279676,"version":"build-2803163510"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shaanxi Key Laboratory of Traditional Chinese Medicine","award":["2022-ZXY-SYS-002"],"award-info":[{"award-number":["2022-ZXY-SYS-002"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003047"],"award-info":[{"award-number":["82003047"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["xzy012020061"],"award-info":[{"award-number":["xzy012020061"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the research fund from the Second Affiliated Hospital of Xi\u2019an Jiaotong University","award":["2020YJ(ZYTS)381"],"award-info":[{"award-number":["2020YJ(ZYTS)381"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Several observational studies have explored the associations between Sj\u00f6gren\u2019s syndrome (SS) and certain cancers. Nevertheless, the causal relationships remain unclear. Mendelian randomization (MR) method was used to investigate the causality between SS and different types of cancers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted the two-sample Mendelian randomization with the public genome-wide association studies (GWASs) summary statistics in European population to evaluate the causality between SS and nine types of cancers. The sample size varies from 1080 to 372,373. The inverse variance weighted (IVW) method was used to estimate the causal effects. A Bonferroni-corrected threshold of <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0031 was considered significant, and <jats:italic>P<\/jats:italic> value between 0.0031 and 0.05 was considered to be suggestive of an association. Sensitivity analysis was performed to validate the causality. Moreover, additional analysis was used to assess the associations between SS and well-accepted risk factors of cancers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After correcting the heterogeneity and horizontal pleiotropy, the results indicated that patients with SS were significantly associated with an increased risk of lymphomas (odds ratio [OR]\u2009=\u20091.0010, 95% confidence interval [CI]: 1.0005\u20131.0015, <jats:italic>P<\/jats:italic>\u2009=\u20090.0002) and reduced risks of prostate cancer (OR\u2009=\u20090.9972, 95% CI: 0.9960\u20130.9985, <jats:italic>P<\/jats:italic>\u2009=\u20092.45\u2009\u00d7\u200910<jats:sup>\u22125<\/jats:sup>) and endometrial cancer (OR\u2009=\u20090.9414, 95% CI: 0.9158\u20130.9676, <jats:italic>P<\/jats:italic>\u2009=\u20091.65\u2009\u00d7\u200910<jats:sup>\u22125<\/jats:sup>). Suggestive associations were found in liver and bile duct cancer (OR\u2009=\u20090.9999, 95% CI: 0.9997\u20131.0000, <jats:italic>P<\/jats:italic>\u2009=\u20090.0291) and cancer of urinary tract (OR\u2009=\u20090.9996, 95% CI: 0.9992\u20131.0000, <jats:italic>P<\/jats:italic>\u2009=\u20090.0281). No causal effect of SS on other cancer types was detected. Additional MR analysis indicated that causal effects between SS and cancers were not mediated by the well-accepted risk factors of cancers. No evidence of the causal relationship was observed for cancers on SS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>SS had significant causal relationships with lymphomas, prostate cancer, and endometrial cancer, and suggestive evidence of association was found in liver and bile duct cancer and cancer of urinary tract, indicating that SS may play a vital role in the incidence of these malignancies.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-023-03157-w","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T10:03:27Z","timestamp":1694772207000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Causal associations of Sj\u00f6gren\u2019s syndrome with cancers: a two-sample Mendelian randomization study"],"prefix":"10.1186","volume":"25","author":[{"given":"Yiwei","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peizhuo","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaofan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingcong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"key":"3157_CR1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","volume":"366","author":"RI Fox","year":"2005","unstructured":"Fox RI. Sj\u00f6gren\u2019s syndrome. Lancet. 2005;366:321\u201331.","journal-title":"Lancet"},{"key":"3157_CR2","doi-asserted-by":"crossref","first-page":"A305","DOI":"10.1016\/j.autrev.2009.11.004","volume":"9","author":"CP Mavragani","year":"2010","unstructured":"Mavragani CP, Moutsopoulos HM. The geoepidemiology of Sj\u00f6gren\u2019s syndrome. Autoimmun Rev. 2010;9:A305\u201310.","journal-title":"Autoimmun Rev"},{"key":"3157_CR3","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.arcmed.2006.08.002","volume":"37","author":"M Garc\u00eda-Carrasco","year":"2006","unstructured":"Garc\u00eda-Carrasco M, Fuentes-Alexandro S, Esc\u00e1rcega RO, Salgado G, Riebeling C, Cervera R. Pathophysiology of Sj\u00f6gren\u2019s syndrome. Arch Med Res. 2006;37:921\u201332.","journal-title":"Arch Med Res"},{"key":"3157_CR4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.autrev.2015.03.004","volume":"14","author":"A Papageorgiou","year":"2015","unstructured":"Papageorgiou A, Voulgarelis M, Tzioufas AG. Clinical picture, outcome and predictive factors of lymphoma in Sj\u04e7gren syndrome. Autoimmun Rev. 2015;14:641\u20139.","journal-title":"Autoimmun Rev"},{"key":"3157_CR5","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1093\/rheumatology\/keab939","volume":"61","author":"LG Chatzis","year":"2022","unstructured":"Chatzis LG, Stergiou IE, Goules AV, Pezoulas V, Tsourouflis G, Fotiadis D, et al. Clinical picture, outcome and predictive factors of lymphoma in primary Sj\u00f6gren\u2019s syndrome: results from a harmonized dataset (1981\u20132021). Rheumatology (Oxford). 2022;61:3576\u201385.","journal-title":"Rheumatology (Oxford)"},{"key":"3157_CR6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13045-017-0464-5","volume":"10","author":"P Brito-Zer\u00f3n","year":"2017","unstructured":"Brito-Zer\u00f3n P, Kostov B, Fraile G, Caravia-Dur\u00e1n D, Maure B, Rasc\u00f3n FJ, et al. Characterization and risk estimate of cancer in patients with primary Sj\u00f6gren syndrome. J Hematol Oncol. 2017;10:90.","journal-title":"J Hematol Oncol"},{"key":"3157_CR7","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/1756-185X.13927","volume":"23","author":"J Kang","year":"2020","unstructured":"Kang J, Kim H, Kim J, Choi S, Jung SY, Jang EJ, et al. Risk of malignancy in Korean patients with primary Sj\u00f6gren\u2019s syndrome. Int J Rheum Dis. 2020;23:1240\u20137.","journal-title":"Int J Rheum Dis"},{"key":"3157_CR8","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/rheumatology\/kei281","volume":"45","author":"MN Lazarus","year":"2006","unstructured":"Lazarus MN, Robinson D, Mak V, M\u00f8ller H, Isenberg DA. Incidence of cancer in a cohort of patients with primary Sjogren\u2019s syndrome. Rheumatology (Oxford). 2006;45:1012\u20135.","journal-title":"Rheumatology (Oxford)"},{"key":"3157_CR9","doi-asserted-by":"crossref","first-page":"102987","DOI":"10.1016\/j.autrev.2021.102987","volume":"20","author":"R Goulabchand","year":"2021","unstructured":"Goulabchand R, Malafaye N, Jacot W, WitkowskiDurandViel P, Morel J, Lukas C, et al. Cancer incidence in primary Sj\u00f6gren\u2019s syndrome: data from the French hospitalization database. Autoimmun Rev. 2021;20:102987.","journal-title":"Autoimmun Rev"},{"key":"3157_CR10","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s00296-019-04433-2","volume":"39","author":"M Brom","year":"2019","unstructured":"Brom M, Moyano S, Gandino IJ, Scolnik M, Soriano ER. Incidence of cancer in a cohort of patients with primary Sj\u00f6gren syndrome in Argentina. Rheumatol Int. 2019;39:1697\u2013702.","journal-title":"Rheumatol Int"},{"key":"3157_CR11","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/annrheumdis-2014-206998","volume":"75","author":"C Miceli-Richard","year":"2016","unstructured":"Miceli-Richard C, Wang-Renault SF, Boudaoud S, Busato F, Lallemand C, Bethune K, et al. Overlap between differentially methylated DNA regions in blood B lymphocytes and genetic at-risk loci in primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis. 2016;75:933\u201340.","journal-title":"Ann Rheum Dis"},{"key":"3157_CR12","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1136\/annrheumdis-2015-208659","volume":"75","author":"J Imgenberg-Kreuz","year":"2016","unstructured":"Imgenberg-Kreuz J, Sandling JK, Alml\u00f6f JC, Nordlund J, Sign\u00e9r L, Norheim KB, et al. Genome-wide DNA methylation analysis in multiple tissues in primary Sj\u00f6gren\u2019s syndrome reveals regulatory effects at interferon-induced genes. Ann Rheum Dis. 2016;75:2029\u201336.","journal-title":"Ann Rheum Dis"},{"key":"3157_CR13","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1111\/bph.12885","volume":"172","author":"D Cheishvili","year":"2015","unstructured":"Cheishvili D, Boureau L, Szyf M. DNA demethylation and invasive cancer: implications for therapeutics. Br J Pharmacol. 2015;172:2705\u201315.","journal-title":"Br J Pharmacol"},{"key":"3157_CR14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12032-022-01943-1","volume":"40","author":"S Bhootra","year":"2023","unstructured":"Bhootra S, Jill N, Shanmugam G, Rakshit S, Sarkar K. DNA methylation and cancer: transcriptional regulation, prognostic, and therapeutic perspective. Med Oncol. 2023;40:71.","journal-title":"Med Oncol"},{"key":"3157_CR15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/annrheumdis-2017-211417","volume":"77","author":"SF Wang-Renault","year":"2018","unstructured":"Wang-Renault SF, Boudaoud S, Nocturne G, Roche E, Sigrist N, Daviaud C, et al. Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis. 2018;77:133\u201340.","journal-title":"Ann Rheum Dis"},{"key":"3157_CR16","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/eji.201040757","volume":"41","author":"KM Pauley","year":"2011","unstructured":"Pauley KM, Stewart CM, Gauna AE, Dupre LC, Kuklani R, Chan AL, et al. Altered miR-146a expression in Sj\u00f6gren\u2019s syndrome and its functional role in innate immunity. Eur J Immunol. 2011;41:2029\u201339.","journal-title":"Eur J Immunol"},{"key":"3157_CR17","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.3892\/ol.2017.6477","volume":"14","author":"M Wilczy\u0144ski","year":"2017","unstructured":"Wilczy\u0144ski M, \u017bytko E, Szyma\u0144ska B, Dzieniecka M, Nowak M, Danielska J, et al. Expression of miR-146a in patients with ovarian cancer and its clinical significance. Oncol Lett. 2017;14:3207\u201314.","journal-title":"Oncol Lett"},{"key":"3157_CR18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-4598-14-5","volume":"14","author":"Z Zhang","year":"2015","unstructured":"Zhang Z, Zhang Y, Sun XX, Ma X, Chen ZN. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma. Mol Cancer. 2015;14:5.","journal-title":"Mol Cancer"},{"key":"3157_CR19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/jb\/mvz079","volume":"167","author":"J Chen","year":"2020","unstructured":"Chen J, Jiang Q, Jiang XQ, Li DQ, Jiang XC, Wu XB, et al. miR-146a promoted breast cancer proliferation and invasion by regulating NM23-H1. J Biochem. 2020;167:41\u20138.","journal-title":"J Biochem"},{"key":"3157_CR20","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/mt.2014.105","volume":"22","author":"SY Park","year":"2014","unstructured":"Park SY, Kim H, Yoon S, Bae JA, Choi SY, Jung YD, et al. KITENIN-targeting microRNA-124 suppresses colorectal cancer cell motility and tumorigenesis. Mol Ther. 2014;22:1653\u201364.","journal-title":"Mol Ther"},{"key":"3157_CR21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4149\/neo_2018_170217N118","volume":"65","author":"Z Qi","year":"2018","unstructured":"Qi Z, Zhang B, Zhang J, Hu Q, Xu F, Chen B, et al. MicroRNA-30b inhibits non-small cell lung cancer cell growth by targeting the epidermal growth factor receptor. Neoplasma. 2018;65:192\u2013200.","journal-title":"Neoplasma"},{"key":"3157_CR22","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/ng.2792","volume":"45","author":"CJ Lessard","year":"2013","unstructured":"Lessard CJ, Li H, Adrianto I, Ice JA, Rasmussen A, Grundahl KM, et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sj\u00f6gren\u2019s syndrome. Nat Genet. 2013;45:1284\u201392.","journal-title":"Nat Genet"},{"key":"3157_CR23","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1158\/1541-7786.MCR-21-0886","volume":"20","author":"X Gong","year":"2022","unstructured":"Gong X, Karchin R. Pan-cancer HLA gene-mediated tumor immunogenicity and immune evasion. Mol Cancer Res. 2022;20:1272\u201383.","journal-title":"Mol Cancer Res"},{"key":"3157_CR24","first-page":"184","volume":"60","author":"M Jaiswal","year":"2000","unstructured":"Jaiswal M, LaRusso NF, Burgart LJ, Gores GJ. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res. 2000;60:184\u201390.","journal-title":"Cancer Res"},{"key":"3157_CR25","doi-asserted-by":"crossref","first-page":"7186","DOI":"10.1158\/1078-0432.CCR-09-1425","volume":"15","author":"J George","year":"2009","unstructured":"George J, Banik NL, Ray SK. Combination of hTERT knockdown and IFN-gamma treatment inhibited angiogenesis and tumor progression in glioblastoma. Clin Cancer Res. 2009;15:7186\u201395.","journal-title":"Clin Cancer Res"},{"key":"3157_CR26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.smim.2014.01.001","volume":"26","author":"K Taniguchi","year":"2014","unstructured":"Taniguchi K, Karin M. IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. Semin Immunol. 2014;26:54\u201374.","journal-title":"Semin Immunol"},{"key":"3157_CR27","first-page":"177","volume":"5","author":"CP El-Haibi","year":"2012","unstructured":"El-Haibi CP, Singh R, Gupta P, Sharma PK, Greenleaf KN, Singh S, et al. Antibody microarray analysis of signaling networks regulated by Cxcl13 and Cxcr5 in prostate cancer. J Proteomics Bioinform. 2012;5:177\u201384.","journal-title":"J Proteomics Bioinform"},{"key":"3157_CR28","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017;318:1925\u20136.","journal-title":"JAMA"},{"key":"3157_CR29","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/ije\/dyv071","volume":"44","author":"AG Boef","year":"2015","unstructured":"Boef AG, Dekkers OM, le Cessie S. Mendelian randomization studies: a review of the approaches used and the quality of reporting. Int J Epidemiol. 2015;44:496\u2013511.","journal-title":"Int J Epidemiol"},{"key":"3157_CR30","doi-asserted-by":"crossref","first-page":"e1006820","DOI":"10.1371\/journal.pgen.1006820","volume":"13","author":"H Li","year":"2017","unstructured":"Li H, Reksten TR, Ice JA, Kelly JA, Adrianto I, Rasmussen A, et al. Identification of a Sj\u00f6gren\u2019s syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons. PLoS Genet. 2017;13:e1006820.","journal-title":"PLoS Genet"},{"key":"3157_CR31","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1093\/hmg\/ddx135","volume":"26","author":"R Carapito","year":"2017","unstructured":"Carapito R, Gottenberg JE, Kotova I, Untrau M, Michel S, Naegely L, et al. A new MHC-linked susceptibility locus for primary Sj\u00f6gren\u2019s syndrome: MICA. Hum Mol Genet. 2017;26:2565\u201376.","journal-title":"Hum Mol Genet"},{"key":"3157_CR32","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/art.40040","volume":"69","author":"KE Taylor","year":"2017","unstructured":"Taylor KE, Wong Q, Levine DM, McHugh C, Laurie C, Doheny K, et al. Genome-wide association analysis reveals genetic heterogeneity of Sj\u00f6gren\u2019s syndrome according to ancestry. Arthritis Rheumatol. 2017;69:1294\u2013305.","journal-title":"Arthritis Rheumatol"},{"key":"3157_CR33","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1038\/s41467-022-30773-y","volume":"13","author":"B Khatri","year":"2022","unstructured":"Khatri B, Tessneer KL, Rasmussen A, Aghakhanian F, Reksten TR, Adler A, et al. Genome-wide association study identifies Sj\u00f6gren\u2019s risk loci with functional implications in immune and glandular cells. Nat Commun. 2022;13:4287.","journal-title":"Nat Commun"},{"key":"3157_CR34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature24284","volume":"551","author":"K Michailidou","year":"2017","unstructured":"Michailidou K, Lindstr\u00f6m S, Dennis J, Beesley J, Hui S, Kar S, et al. Association analysis identifies 65 new breast cancer risk loci. Nature. 2017;551:92\u20134.","journal-title":"Nature"},{"key":"3157_CR35","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41588-020-0609-2","volume":"52","author":"H Zhang","year":"2020","unstructured":"Zhang H, Ahearn TU, Lecarpentier J, Barnes D, Beesley J, Qi G, et al. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nat Genet. 2020;52:572\u201381.","journal-title":"Nat Genet"},{"key":"3157_CR36","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/ng0417-651a","volume":"49","author":"Y Wang","year":"2017","unstructured":"Wang Y, McKay JD, Rafnar T, Wang Z, Timofeeva MN, Broderick P, et al. Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet. 2017;49:651.","journal-title":"Nat Genet"},{"key":"3157_CR37","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1038\/s41467-018-05427-7","volume":"9","author":"TA O\u2019Mara","year":"2018","unstructured":"O\u2019Mara TA, Glubb DM, Amant F, Annibali D, Ashton K, Attia J, et al. Identification of nine new susceptibility loci for endometrial cancer. Nat Commun. 2018;9:3166.","journal-title":"Nat Commun"},{"key":"3157_CR38","doi-asserted-by":"crossref","first-page":"E1674","DOI":"10.1210\/jc.2013-1941","volume":"98","author":"A K\u00f6hler","year":"2013","unstructured":"K\u00f6hler A, Chen B, Gemignani F, Elisei R, Romei C, Figlioli G, et al. Genome-wide association study on differentiated thyroid cancer. J Clin Endocrinol Metab. 2013;98:E1674\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"3157_CR39","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/ng.3685","volume":"48","author":"C Lesseur","year":"2016","unstructured":"Lesseur C, Diergaarde B, Olshan AF, W\u00fcnsch-Filho V, Ness AR, Liu G, et al. Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer. Nat Genet. 2016;48:1544\u201350.","journal-title":"Nat Genet"},{"key":"3157_CR40","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1038\/s41588-018-0248-z","volume":"50","author":"O Canela-Xandri","year":"2018","unstructured":"Canela-Xandri O, Rawlik K, Tenesa A. An atlas of genetic associations in UK Biobank. Nat Genet. 2018;50:1593\u20139.","journal-title":"Nat Genet"},{"key":"3157_CR41","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/ije\/dyt179","volume":"42","author":"MJ Brion","year":"2013","unstructured":"Brion MJ, Shakhbazov K, Visscher PM. Calculating statistical power in Mendelian randomization studies. Int J Epidemiol. 2013;42:1497\u2013501.","journal-title":"Int J Epidemiol"},{"key":"3157_CR42","doi-asserted-by":"crossref","first-page":"742952","DOI":"10.3389\/fpubh.2021.742952","volume":"9","author":"M Wang","year":"2021","unstructured":"Wang M, Jian Z, Gao X, Yuan C, Jin X, Li H, et al. Causal associations between educational attainment and 14 urological and reproductive health outcomes: a Mendelian randomization study. Front Public Health. 2021;9:742952.","journal-title":"Front Public Health"},{"key":"3157_CR43","doi-asserted-by":"crossref","first-page":"993731","DOI":"10.3389\/fgene.2022.993731","volume":"13","author":"Q Wang","year":"2022","unstructured":"Wang Q, Wang R, Chen C, Feng Y, Ye Z, Zhan M, et al. Educational attainment and endometrial cancer: a Mendelian randomization study. Front Genet. 2022;13:993731.","journal-title":"Front Genet"},{"key":"3157_CR44","doi-asserted-by":"crossref","first-page":"e1003178","DOI":"10.1371\/journal.pmed.1003178","volume":"17","author":"SC Larsson","year":"2020","unstructured":"Larsson SC, Carter P, Kar S, Vithayathil M, Mason AM, Micha\u00eblsson K, et al. Smoking, alcohol consumption, and cancer: a Mendelian randomisation study in UK Biobank and international genetic consortia participants. PLoS Med. 2020;17:e1003178.","journal-title":"PLoS Med"},{"key":"3157_CR45","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1038\/s41366-021-00942-y","volume":"45","author":"M Ahmed","year":"2021","unstructured":"Ahmed M, Mulugeta A, Lee SH, M\u00e4kinen VP, Boyle T, Hypp\u00f6nen E. Adiposity and cancer: a Mendelian randomization analysis in the UK biobank. Int J Obes (Lond). 2021;45:2657\u201365.","journal-title":"Int J Obes (Lond)"},{"key":"3157_CR46","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41588-018-0147-3","volume":"50","author":"JJ Lee","year":"2018","unstructured":"Lee JJ, Wedow R, Okbay A, Kong E, Maghzian O, Zacher M, et al. Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. Nat Genet. 2018;50:1112\u201321.","journal-title":"Nat Genet"},{"key":"3157_CR47","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41588-018-0307-5","volume":"51","author":"M Liu","year":"2019","unstructured":"Liu M, Jiang Y, Wedow R, Li Y, Brazel DM, Chen F, et al. Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use. Nat Genet. 2019;51:237\u201344.","journal-title":"Nat Genet"},{"key":"3157_CR48","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","volume":"37","author":"S Burgess","year":"2013","unstructured":"Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658\u201365.","journal-title":"Genet Epidemiol"},{"key":"3157_CR49","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32:377\u201389.","journal-title":"Eur J Epidemiol"},{"key":"3157_CR50","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304\u201314.","journal-title":"Genet Epidemiol"},{"key":"3157_CR51","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693\u20138.","journal-title":"Nat Genet"},{"key":"3157_CR52","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-89-6-888","volume":"89","author":"SS Kassan","year":"1978","unstructured":"Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med. 1978;89:888\u201392.","journal-title":"Ann Intern Med"},{"key":"3157_CR53","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","volume":"65","author":"E Theander","year":"2006","unstructured":"Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LT. Lymphoma and other malignancies in primary Sj\u00f6gren\u2019s syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis. 2006;65:796\u2013803.","journal-title":"Ann Rheum Dis"},{"key":"3157_CR54","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrrheum.2018.1","volume":"14","author":"G Nocturne","year":"2018","unstructured":"Nocturne G, Mariette X. B cells in the pathogenesis of primary Sj\u00f6gren syndrome. Nat Rev Rheumatol. 2018;14:133\u201345.","journal-title":"Nat Rev Rheumatol"},{"key":"3157_CR55","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jaut.2015.07.002","volume":"63","author":"A Nezos","year":"2015","unstructured":"Nezos A, Gravani F, Tassidou A, Kapsogeorgou EK, Voulgarelis M, Koutsilieris M, et al. Type I and II interferon signatures in Sjogren\u2019s syndrome pathogenesis: contributions in distinct clinical phenotypes and Sjogren\u2019s related lymphomagenesis. J Autoimmun. 2015;63:47\u201358.","journal-title":"J Autoimmun"},{"key":"3157_CR56","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1002\/art.27611","volume":"62","author":"GJ Tob\u00f3n","year":"2010","unstructured":"Tob\u00f3n GJ, Renaudineau Y, Hillion S, Cornec D, Devauchelle-Pensec V, Youinou P, et al. The Fms-like tyrosine kinase 3 ligand, a mediator of B cell survival, is also a marker of lymphoma in primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheum. 2010;62:3447\u201356.","journal-title":"Arthritis Rheum"},{"key":"3157_CR57","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1182\/blood-2013-05-503383","volume":"122","author":"G Nocturne","year":"2013","unstructured":"Nocturne G, Boudaoud S, Miceli-Richard C, Viengchareun S, Lazure T, Nititham J, et al. Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren\u2019s syndrome. Blood. 2013;122:4068\u201376.","journal-title":"Blood"},{"key":"3157_CR58","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/1529-0131(199907)42:7<1466::AID-ANR21>3.0.CO;2-L","volume":"42","author":"NI Tapinos","year":"1999","unstructured":"Tapinos NI, Polihronis M, Moutsopoulos HM. Lymphoma development in Sj\u00f6gren\u2019s syndrome: novel p53 mutations. Arthritis Rheum. 1999;42:1466\u201372.","journal-title":"Arthritis Rheum"},{"key":"3157_CR59","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5114\/reum.2017.68913","volume":"55","author":"C Manzo","year":"2017","unstructured":"Manzo C, Kechida M. Is primary Sj\u00f6gren\u2019s syndrome a risk factor for malignancies different from lymphomas? What does the literature highlight about it? Reumatologia. 2017;55:136\u20139.","journal-title":"Reumatologia"},{"key":"3157_CR60","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2013-203305","volume":"73","author":"Y Liang","year":"2014","unstructured":"Liang Y, Yang Z, Qin B, Zhong R. Primary Sjogren\u2019s syndrome and malignancy risk: a systematic review and meta-analysis. Ann Rheum Dis. 2014;73:1151\u20136.","journal-title":"Ann Rheum Dis"},{"key":"3157_CR61","doi-asserted-by":"crossref","first-page":"103084","DOI":"10.1016\/j.autrev.2022.103084","volume":"21","author":"H Zhong","year":"2022","unstructured":"Zhong H, Liu S, Wang Y, Xu D, Li M, Zhao Y, et al. Primary Sj\u00f6gren\u2019s syndrome is associated with increased risk of malignancies besides lymphoma: a systematic review and meta-analysis. Autoimmun Rev. 2022;21:103084.","journal-title":"Autoimmun Rev"},{"key":"3157_CR62","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/sj.bjc.6604906","volume":"100","author":"SM Gadalla","year":"2009","unstructured":"Gadalla SM, Amr S, Langenberg P, Baumgarten M, Davidson WF, Schairer C, et al. Breast cancer risk in elderly women with systemic autoimmune rheumatic diseases: a population-based case-control study. Br J Cancer. 2009;100:817\u201321.","journal-title":"Br J Cancer"},{"key":"3157_CR63","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.3390\/jcm11154272","volume":"11","author":"E Treppo","year":"2022","unstructured":"Treppo E, Toffolutti F, Manfr\u00e8 V, Taborelli M, De Marchi G, De Vita S, et al. Risk of cancer in connective tissue diseases in Northeastern Italy over 15 years. J Clin Med. 2022;11:4272.","journal-title":"J Clin Med"},{"key":"3157_CR64","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.3899\/jrheum.191027","volume":"47","author":"LH Wang","year":"2020","unstructured":"Wang LH, Wang WM, Lin CY, Lin SH, Shieh CC. Bidirectional relationship between primary Sj\u00f6gren syndrome and non-Hodgkin lymphoma: a nationwide Taiwanese population-based study. J Rheumatol. 2020;47:1374\u20138.","journal-title":"J Rheumatol"},{"key":"3157_CR65","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jsbmb.2014.08.014","volume":"145","author":"YT Konttinen","year":"2015","unstructured":"Konttinen YT, Stegajev V, Al-Samadi A, Porola P, Hietanen J, Ainola M. Sj\u00f6gren\u2019s syndome and extragonadal sex steroid formation: a clue to a better disease control? J Steroid Biochem Mol Biol. 2015;145:237\u201344.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"3157_CR66","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/acr.24014","volume":"72","author":"SS McCoy","year":"2020","unstructured":"McCoy SS, Sampene E, Baer AN. Association of Sj\u00f6gren\u2019s syndrome with reduced lifetime sex hormone exposure: a case-control study. Arthritis Care Res (Hoboken). 2020;72:1315\u201322.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"3157_CR67","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev-physiol-030212-183708","volume":"75","author":"J Liang","year":"2013","unstructured":"Liang J, Shang Y. Estrogen and cancer. Annu Rev Physiol. 2013;75:225\u201340.","journal-title":"Annu Rev Physiol"},{"key":"3157_CR68","doi-asserted-by":"crossref","first-page":"e1171447","DOI":"10.1080\/2162402X.2016.1171447","volume":"6","author":"B Seliger","year":"2017","unstructured":"Seliger B, Kloor M, Ferrone S. HLA class II antigen-processing pathway in tumors: molecular defects and clinical relevance. Oncoimmunology. 2017;6:e1171447.","journal-title":"Oncoimmunology"},{"key":"3157_CR69","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.3324\/haematol.2009.008862","volume":"94","author":"HW Bernd","year":"2009","unstructured":"Bernd HW, Ziepert M, Thorns C, Klapper W, Wacker HH, Hummel M, et al. Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials. Haematologica. 2009;94:1569\u201380.","journal-title":"Haematologica"},{"key":"3157_CR70","first-page":"269","volume":"23","author":"ACh Lazaris","year":"2004","unstructured":"Lazaris ACh, Chatzigianni EB, Xidias G, Panoskaltsis TA, Thomopoulou GC, Eftychiadis CA, et al. Tissue evaluation of immune markers in endometrial and cervical carcinomas. J Exp Clin Cancer Res. 2004;23:269\u201375.","journal-title":"J Exp Clin Cancer Res"},{"key":"3157_CR71","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/pros.21078","volume":"70","author":"S Vuk-Pavlovi\u0107","year":"2010","unstructured":"Vuk-Pavlovi\u0107 S, Bulur PA, Lin Y, Qin R, Szumlanski CL, Zhao X, et al. Immunosuppressive CD14+HLA-DRlow\/- monocytes in prostate cancer. Prostate. 2010;70:443\u201355.","journal-title":"Prostate"},{"key":"3157_CR72","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ijc.20860","volume":"115","author":"K Matoba","year":"2005","unstructured":"Matoba K, Iizuka N, Gondo T, Ishihara T, Yamada-Okabe H, Tamesa T, et al. Tumor HLA-DR expression linked to early intrahepatic recurrence of hepatocellular carcinoma. Int J Cancer. 2005;115:231\u201340.","journal-title":"Int J Cancer"},{"key":"3157_CR73","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/medicina58020190","volume":"58","author":"CK Balakrishnan","year":"2022","unstructured":"Balakrishnan CK, Tye GJ, Balasubramaniam SD, Kaur G. CD74 and HLA-DRA in cervical carcinogenesis: potential targets for antitumour therapy. Medicina (Kaunas). 2022;58:190.","journal-title":"Medicina (Kaunas)"},{"issue":"237","key":"3157_CR74","first-page":"e21","volume":"39","author":"XM Piao","year":"2021","unstructured":"Piao XM, Kang HW, Jeong P, Byun YJ, Lee HY, Kim K, et al. A prognostic immune predictor, HLA-DRA, plays diverse roles in non-muscle invasive and muscle invasive bladder cancer. Urol Oncol. 2021;39(237):e21-237.e29.","journal-title":"Urol Oncol"},{"key":"3157_CR75","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1349-7006.2006.00137.x","volume":"97","author":"K Matsushita","year":"2006","unstructured":"Matsushita K, Takenouchi T, Shimada H, Tomonaga T, Hayashi H, Shioya A, et al. Strong HLA-DR antigen expression on cancer cells relates to better prognosis of colorectal cancer patients: possible involvement of c-myc suppression by interferon-gamma in situ. Cancer Sci. 2006;97:57\u201363.","journal-title":"Cancer Sci"},{"key":"3157_CR76","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.4161\/cbt.3.10.1142","volume":"3","author":"LB Rangel","year":"2004","unstructured":"Rangel LB, Agarwal R, Sherman-Baust CA, Mello-Coelho Vd, Pizer ES, Ji H, et al. Anomalous expression of the HLA-DR alpha and beta chains in ovarian and other cancers. Cancer Biol Ther. 2004;3:1021\u20137.","journal-title":"Cancer Biol Ther"},{"key":"3157_CR77","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cac2.12283","volume":"42","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Liu H, Yang Y, Zhou J, Zhao L, Chen H, et al. The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large-scale cohort study in China. Cancer Commun (Lond). 2022;42:435\u201346.","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"3157_CR78","doi-asserted-by":"crossref","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","volume":"2","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n P, Baldini C, Bootsma H, Bowman SJ, Jonsson R, Mariette X, et al. Sj\u00f6gren syndrome. Nat Rev Dis Primers. 2016;2(1):16047.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"3157_CR79","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/1352458507083625","volume":"14","author":"C Lebrun","year":"2008","unstructured":"Lebrun C, Debouverie M, Vermersch P, Clavelou P, Rumbach L, de Seze J, et al. Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis. Mult Scler. 2008;14(3):399\u2013405.","journal-title":"Mult Scler"},{"issue":"2","key":"3157_CR80","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ophtha.2014.08.024","volume":"122","author":"WB Yates","year":"2015","unstructured":"Yates WB, Vajdic CM, Na R, McCluskey PJ, Wakefield D. Malignancy risk in patients with inflammatory eye disease treated with systemic immunosuppressive therapy: a tertiary referral cohort study. Ophthalmology. 2015;122(2):265\u201373.","journal-title":"Ophthalmology"},{"issue":"10","key":"3157_CR81","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3949\/ccjm.64.10.523","volume":"64","author":"G Linardaki","year":"1997","unstructured":"Linardaki G, Moutsopoulos HM. The uncertain role of immunosuppressive agents in Sj\u00f6gren\u2019s syndrome. Cleve Clin J Med. 1997;64(10):523\u20136.","journal-title":"Cleve Clin J Med"},{"issue":"3","key":"3157_CR82","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jaad.2022.11.043","volume":"88","author":"MA Kreher","year":"2023","unstructured":"Kreher MA, Konda S, Noland MMB, Longo MI, Valdes-Rodriguez R. Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part II: methotrexate, alkylating agents, biologics, and small molecule inhibitors. J Am Acad Dermatol. 2023;88(3):534\u201342.","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"3157_CR83","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/rheumatology\/kew214","volume":"55","author":"E Lange","year":"2016","unstructured":"Lange E, Blizzard L, Venn A, Francis H, Jones G. Disease-modifying anti-rheumatic drugs and non-melanoma skin cancer in inflammatory arthritis patients: a retrospective cohort study. Rheumatology (Oxford). 2016;55(9):1594\u2013600.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"3157_CR84","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jamadermatol.2015.3029","volume":"152","author":"FI Scott","year":"2016","unstructured":"Scott FI, Mamtani R, Brensinger CM, Haynes K, Chiesa-Fuxench ZC, Zhang J, et al. Risk of Nonmelanoma skin cancer associated with the use of immunosuppressant and biologic agents in patients with a history of autoimmune disease and nonmelanoma skin cancer. JAMA Dermatol. 2016;152(2):164\u201372.","journal-title":"JAMA Dermatol"},{"key":"3157_CR85","volume":"12","author":"YH Chen","year":"2021","unstructured":"Chen YH, Wang XY, Jin X, Yang Z, Xu J. Rituximab therapy for primary Sj\u00f6gren\u2019s syndrome. Front Pharmacol. 2021;12: 731122.","journal-title":"Front Pharmacol"},{"issue":"5","key":"3157_CR86","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ana.25701","volume":"87","author":"P Alping","year":"2020","unstructured":"Alping P, Askling J, Burman J, Fink K, Fogdell-Hahn A, Gunnarsson M, et al. Cancer risk for fingolimod, natalizumab, and rituximab in multiple sclerosis patients. Ann Neurol. 2020;87(5):688\u201399.","journal-title":"Ann Neurol"},{"issue":"2","key":"3157_CR87","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.bbrc.2018.01.107","volume":"496","author":"C Zhang","year":"2018","unstructured":"Zhang C, Chu M. Leflunomide: a promising drug with good antitumor potential. Biochem Biophys Res Commun. 2018;496(2):726\u201330.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-03157-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-023-03157-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-03157-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T07:17:48Z","timestamp":1700291868000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-023-03157-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3157"],"URL":"https:\/\/doi.org\/10.1186\/s13075-023-03157-w","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]},"assertion":[{"value":"5 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the studies used to compliment the current study were approved by relevant ethics committees. All participants involved provided a written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}